Lightnews — Scholar-powered news

IDSA @idsainfo.bsky.social · 14h

Looking for career opportunities in infectious diseases? 🔍 Visit the IDSA Career Fair at #IDWeek2025 on Mon. Oct. 20 at 6pm-8pm ET in B Lobby to connect with top employers and explore open positions in research, clinical care, public health and more.

1 1 2

IDSA @idsainfo.bsky.social · 1d

In CID, Wuyan Zhang and colleagues evaluate whether participants with COVID-19 symptom recurrence and viral positivity after completion of nirmatrelvir/ritonavir treatment can benefit from a second course of treatment. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf548/8269311

Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity

Repeated nirmatrelvir/ritonavir treatment in participants with COVID-19 rebound was safe and well tolerated. In this group of participants, there was no cl

academic.oup.com

2

IDSA @idsainfo.bsky.social · 2d

"I just wish I knew the magic words to reach people willing to jettison decades of evidence and research for something they read online," writes IDSA member Morgan Goheen, MD, PhD, in a new HuffPost op-ed on how open dialogue can help bridge divides over infectious diseases. https://bit.ly/4nDdMav

I Sat Next To An Anti-Vax Conspiracy Theorist On A Plane. Then I Told Him What I Do For A Living.

"As someone who recently completed 15 years of training to become an infectious diseases physician-scientist, I can't avoid these conversations."

www.huffpost.com

8 21

IDSA @idsainfo.bsky.social · 2d

On IDSA’s & HIVMA’s Science Speaks blog: Eva Clark, MD, PhD, CTropMed, reflects on the health care dilemmas U.S. immigrants are facing, what these experiences reveal and how to address this crisis. https://bit.ly/437oXQl

When home becomes alien: Health care dilemmas faced by U.S. immigrants

Eva Clark, MD, PhD, CTropMed, reflects on the health care dilemmas that many U.S. immigrants are facing, what these experiences reveal and how to address this crisis.

www.idsociety.org

1 4

IDSA @idsainfo.bsky.social · 4d

On IDSA’s & HIVMA’s Science Speaks blog: Read JID’s latest monthly roundup of papers relevant to clinicians, including articles on a cluster of novel enterovirus cases, cancer risk after TB among people with HIV and other research ready to inform clinical practice. https://bit.ly/3IqghOd

JID for Clinicians: Antibiotic exposure risk in early childhood, cancer risk after TB among people with HIV and more

Learn about novel enterovirus cases, a new potential strategy to mitigate resistance development in cavitary tuberculosis and other research ready to inform clinical practice.

www.idsociety.org

1

IDSA @idsainfo.bsky.social · 5d

Tickets are available for the Dr. George W. Counts Interest Group dinner at #IDWeek2025! Connect with colleagues who are committed to advancing health equity in the field of ID.

📍 Thrive Restaurant in downtown Atlanta
🕒 Sunday, Oct. 19, from 6:30 to 10 p.m. ET.
🎫: https://bit.ly/46BRSOE

2

IDSA @idsainfo.bsky.social · 6d

NIH-funded research is critical to improve the lives of patients, stresses Dr. Lautenbach. Take 2 min and urge your congressional representative to support funding for federal ID & HIV programs: idsociety.quorum.us/campaign/137... #FundNIH

Infectious Diseases Society of America

idsociety.quorum.us

2 1

IDSA @idsainfo.bsky.social · 6d

"We recently had a study on reducing infections in newborns halted. Not being able to complete this work has serious negative implications for being able to take care of these vulnerable newborns," shared ID physician Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, of @pennmedicine.bsky.social.

2 5 6

IDSA @idsainfo.bsky.social · 7d

Less than 7% of all physicians in the U.S. are Latino, despite 19% of the population identifying as Latino. Having Latinos better represented in medicine is necessary for the Latino community and the future of medicine in the U.S.

Learn more: https://www.nationallatinophysicianday.com/ #NLPD2025

6 15

IDSA @idsainfo.bsky.social · 8d

The duration of infectiousness following pulmonary tuberculosis treatment initiation is uncertain.

In CID, authors assess whether a bundled intervention designed to decrease respiratory exposure was feasible and would reduce new tuberculosis infections in household contacts. https://bit.ly/4pK8R9b

Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial

AbstractBackground. The duration of infectiousness following pulmonary tuberculosis treatment initiation remains uncertain. We aimed to assess whether a bu

academic.oup.com

6

IDSA @idsainfo.bsky.social · 8d

A new Department of Health and Human Services video pits vaccines against other health priorities like nutrition, exercise and sanitation. Secretary Kennedy's false dichotomy misrepresents the data, contradicts science and puts lives at risk.

Our response: https://bit.ly/4nWTCb6

9 19

IDSA @idsainfo.bsky.social · 9d

The IDSA Foundation's second annual art auction is now open. Six original paintings by ID physician Ana Velez, MD, FACP, FIDSA, explore retrovirus history and the HIV/AIDS crisis. Auction closes Oct. 21.

Place your bid: https://givebutter.com/c/pclXSb/auction

2 3

IDSA @idsainfo.bsky.social · 9d

On IDSA’s & HIVMA’s Science Speaks blog: Terri Stillwell, MD, MPH, explores the prevalence of co-infection in febrile infants 61-90 days old with and without respiratory viral infection. https://bit.ly/470Myoi

Sometimes it's just a virus, sometimes it's not: Co-infections in febrile infants 61 to 90 days old

A study looked at the prevalence of co-infection in febrile infants 61-90 days old with and without respiratory viral infection. Read IDSA's Journal Club review by Terri Stillwell, MD.

www.idsociety.org

3

IDSA @idsainfo.bsky.social · 10d

The IDSA Foundation is now accepting nominations for the 2025 Diversity Champion Award, to be presented at the Culture Club event. Submit by Oct. 6 to help recognize individuals driving health equity and justice while inspiring diversity and inclusivity in the ID community: buff.ly/y8HpMaM

IDSA Foundation 2025 Diversity Champion

The IDSA Foundation invites nominations for the 2025 Diversity Champion award. Submit a nomination by Monday, Oct. 6, at 11:59 p.m. ET to help us honor and recognize those who elevate diverse…

buff.ly

IDSA @idsainfo.bsky.social · 10d

As you make your #IDWeek2025 plans, don’t miss out on your chance to attend Culture Club: A Celebration of Diversity on Tuesday, Oct. 21, from 7:30 to 11 p.m. ET, hosted by the IDSA Foundation.

Claim your tickets now before they sell out! buff.ly/ogRNEap

2 2

IDSA @idsainfo.bsky.social · 11d

New #LetsTalkID! ID physician and artist Ana Velez, MD, FACP, joins @paulsaxmd.bsky.social to share how art shapes her work in ID and brings new meaning to medicine.

Transcript: bit.ly/3Iu863j

Bid now to own her original artwork and support IDSA's mission: givebutter.com/c/pclXSb/auc...

Blending Art, Medicine and Charity

Ana Velez, MD, FACP, joins Paul Sax, MD, FIDSA, to share how her passion for art fuels her work in infectious diseases.

bit.ly

1 1

IDSA @idsainfo.bsky.social · 12d

IDSA Foundation board member Dr. Jasmine Marcelin explains the importance of a strong ID workforce, and how it can be attained via the Bio-Preparedness Workforce Pilot Program, during a panel at #ALC54.

1 5

Reposted by IDSA

ASM @asm.org · 12d

Leaders in antimicrobial resistance—your voice is needed! Registration is now open for #IMARI26! Join us Jan 28–30, 2026 in Las Vegas for the premier interdisciplinary meeting tackling #AMR, hosted by @idsainfo.bsky.social and ASM. Register now, space is limited: imari.org/registration/

1 4 6

IDSA @idsainfo.bsky.social · 12d

IDSA Foundation board member Dr. Jasmine Marcelin was in DC this week for #ALC54, an event hosted by the Congressional Black Caucus Foundation. Dr. Marcelin spoke on a panel, highlighting IDSA's efforts to diversify the ID workforce, advance health equity and expand access to care.

1 2 9

IDSA @idsainfo.bsky.social · 14d

ID physicians andrewpaviamd.bsky.social and Helen Y. Chu, MD, FIDSA, discuss last week’s meeting of the Advisory Committee on Immunization Practices, the confusion it has caused around vaccine recommendations and the potential impacts.

Watch the press briefing: https://bit.ly/4mz9Jum

1 2

IDSA @idsainfo.bsky.social · 15d

Blood-borne viruses (BBV) such as Hepatitis B, Hepatitis C and HIV pose significant personal and public health risks.

In OFID, Liam Townsend, BCh, MB, PHD, and colleagues report outcomes of ten years of an opt-out BBV screening program in a large urban emergency department. https://bit.ly/3KfEw24

Outcomes 10 Years After Implementing an Emergency Department Opt-out Bloodborne Virus Screening Program

Bloodborne virus screening allows for early diagnosis, linkage to care, and prevention of transmission. A decade after its introduction in our emergency de

academic.oup.com

3

IDSA @idsainfo.bsky.social · 16d

🚨 Registration is OPEN for #IMARI26!

Hosted by IDSA & ASM, top leaders in science, policy & industry will gather Jan 28–30 in Las Vegas for an intimate forum tackling #AMR head-on.

Join us: IMARI.org/registration

1 4 4

IDSA @idsainfo.bsky.social · 17d

On IDSA’s & HIVMA’s Science Speaks blog: Three years after mpox made global headlines, the world is seeing two very different realities: one in Africa and another in the rest of the world. Read more from Melvin Sanicas, MD, MSc, MScID, MBA. https://bit.ly/4mlwPob

Mpox in 2025: What we know, what we have and what needs to happen next

Three years after mpox made global headlines, the world is seeing two very different realities: one in Africa, where the virus is surging, and another in the rest of the world.

www.idsociety.org

1

IDSA @idsainfo.bsky.social · 19d

Clinicians: Appropriate, timely use of antifungals helps protect patient health and combat #AntimicrobialResistance. 💊

Save, print, or bookmark CDC’s fungal pneumonia diagnostic algorithms to help recognize and treat: https://bit.ly/4ly0wml #FungalWeek25

3

IDSA @idsainfo.bsky.social · 19d

Secretary Kennedy presents a clear and present danger to the American people and their families. This week, even more of our colleagues in the fields of medicine, public health and patient advocacy join us in calling for his resignation.

Our full statement: https://bit.ly/42zItEV

1 28 74